FM
BNTX icon

Foster & Motley’s BioNTech BNTX Stock Holding History

Foster & Motley’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,229
Closed -$335K – 384
2022
Q4 		$335K Sell
2,229
-1,017
-31% -$157K 0.03% 315
2022
Q3 		$438K Buy
3,246
+144
+5% +$22K 0.04% 269
2022
Q2 		$463K Buy
+3,102
New +$474K 0.04% 262

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Foster & Motley's BNTX Position: Q1 2023 in Review

Foster & Motley sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 2,229 shares — an estimated $335K sold.

Foster & Motley first reported a position in BNTX in Q2 2022 and held it in 3 quarters. The position peaked at $463K in Q2 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Foster & Motley reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Foster & Motley sold 2,229 BioNTech shares in Q1 2023, an estimated $335K.
  • Foster & Motley first reported a position in BioNTech in Q2 2022 and held it in 3 quarters.
  • Foster & Motley's BioNTech position peaked at $463K in Q2 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Foster & Motley's 13F filing for Q1 2023, filed 9 May 2023.